Predicting the response of multiple myeloma to the proteasome inhibitor Bortezomib by evaluation of the unfolded protein response

N. Nikesitch, C. Tao, K. Lai, M. Killingsworth, S. Bae, M. Wang, S. Harrison, T. L. Roberts, S. C. W. Ling

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)
Original languageEnglish
Article numbere432
Number of pages3
JournalBlood Cancer Journal
Volume6
DOIs
Publication statusPublished - 2016

Open Access - Access Right Statement

© The Author(s) 2016. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Keywords

  • myeloma
  • chemotherapy
  • stem cells

Cite this